Access to needle and syringe programs by people who inject image and performance enhancing drugs.
Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, UNSW Australia, Sydney, Australia. Electronic address: JIversen@kirby.unsw.edu.au.
Jenny
J
Iversen
Public Health England, Colindale Avenue, London, United Kingdom; Centre for Research on Drugs and Health Behaviour, London School of Hygiene & Tropical Medicine, United Kingdom.
Vivian D
VD
Hope
Centre for Public Health, Liverpool John Moores University, Liverpool, United Kingdom.
Jim
J
McVeigh
D006801:Humans; D018671:Needle-Exchange Programs; D009339:Needles; D058573:Performance-Enhancing Substances; D015819:Substance Abuse, Intravenous; D013594:Syringes
D058573:Performance-Enhancing Substances